Mirae Asset Global ETFs Holdings’s TG Therapeutics TGTX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.05M	Sell	73,642 -5,801	-7%	-$237K	﹤0.01%	943
2026 Q1	$2.62M	Buy	79,443 +831	+1%	+$24.8K	﹤0.01%	1063
2025 Q4	$2.34M	Buy	78,612 +293	+0.4%	+$9.57K	﹤0.01%	1086
2025 Q3	$2.84M	Sell	78,319 -10,487	-12%	-$345K	﹤0.01%	992
2025 Q2	$3.2M	Sell	88,806 -2,787	-3%	-$104K	0.01%	882
2025 Q1	$3.62M	Sell	91,593 -1,090	-1%	-$36.7K	0.01%	866
2024 Q4	$2.81M	Buy	92,683 +2,890	+3%	+$82.9K	0.01%	958
2024 Q3	$2.11M	Buy	89,793 +7,146	+9%	+$156K	﹤0.01%	1099
2024 Q2	$1.47M	Buy	+82,647	New	+$1.32M	﹤0.01%	1231

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TGTX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its TG Therapeutics (TGTX) stake by 7.3% in Q2 2026, selling an estimated $237K and leaving 73,642 shares worth $4.05M. The position accounts for ﹤0.01% of the portfolio, ranked #943.

Mirae Asset Global ETFs Holdings first reported a position in TGTX in Q2 2024 and has held it in 9 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Mirae Asset Global ETFs Holdings held 73,642 shares of TG Therapeutics worth $4.05M as of Q2 2026.
Mirae Asset Global ETFs Holdings sold 5,801 TG Therapeutics shares in Q2 2026, an estimated $237K.
TG Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #943 holding.
Mirae Asset Global ETFs Holdings first reported a position in TG Therapeutics in Q2 2024 and has held it in 9 quarters since.
427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.